Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA
Author:
Affiliation:
1. Alnylam Pharmaceuticals, 300 Third Street, Cambridge, Massachusetts 02142, United States
2. Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology
Link
https://pubs.acs.org/doi/pdf/10.1021/bc200235q
Reference29 articles.
1. RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2. 2-Modified Oligonucleotides for Antisense Therapeutics
3. Designing highly active siRNAs for therapeutic applications
4. A status report on RNAi therapeutics
5. Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Isolectin B4 (IB4)-conjugated streptavidin for the selective knockdown of proteins in IB4-positive (+) nociceptors;2023-12-18
2. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide;Cells;2023-10-02
3. RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges;Advanced Drug Delivery Reviews;2023-10
4. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking;Cells;2023-09-11
5. Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics;Pharmaceutics;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3